Refocus Group, Inc.

Refocus Group, Inc.

Refocus Group is a medical device company that develops surgical treatments for human vision disorders. Therapeutic targets include presbyopia (commonly known as farsightedness), elevated blood pressure in the eye, and a certain form of glaucoma. Its most advanced device is the Scleral Spacing Procedure, which includes an incision handpiece, implants, and related surgical equipment, that could treat the previously mentioned vision disorders. Medcare Investment owns more than half of the firm.

Contact Details

Office Address

Refocus Group, Inc.
10300 North Central Expressway, Suite 104
Dallas, TX, USA 75231
Phone: (214) 368-0200
Fax: (214) 368-0332

Executives

Chairman

Glen Bradley

President, CEO, and Director

Douglas C. (Doug) Williamson

Business Reviews for Refocus Group, Inc.

Related Companies